Home
About
Overview
Sharing Data
ORCID
Help
History (8)
Phospholipase A2 and spinal cord injury: a novel target for therapeutic intervention.
Revisiting the Risk of Hospital Readmission in Severe Ulcerative Colitis.
Comparison of breast and abdominal adipose tissue mesenchymal stromal/stem cells in support of proliferation of breast cancer cells.
Cardiac myxoma. A retrospective immunohistochemical study.
Sublingual Dexmedetomidine vs Placebo and Acute Agitation Associated With Bipolar Disorder.
See All 8 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Sublingual Dexmedetomidine vs Placebo and Acute Agitation Associated With Bipolar Disorder.
Sublingual Dexmedetomidine vs Placebo and Acute Agitation Associated With Bipolar Disorder. JAMA. 2022 07 12; 328(2):213-214.
View in:
PubMed
subject areas
Administration, Sublingual
Antipsychotic Agents
Bipolar Disorder
Dexmedetomidine
Humans
Hypnotics and Sedatives
Psychomotor Agitation
authors with profiles
Bezalel Dantz